Vibrio, Campylobacter & Helicobacter Flashcards

1
Q

Vibrio genus

A
  • Vibrios are curved, gram-negative rods commonly found in saltwater
  • Grow under aerobic or anaerobic conditions (facultative)
  • Major pathogenic species are
  • V. cholerae
  • V. vulnificus
  • V. parahemolyticus
  • V. alginolyticus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

V. cholerae

A
  • Causative agent of the diarrheal disease cholera. Intestinal fluids are released in voluminous bowel movements, which eventually lead to dehydration and electrolyte imbalance.
  • These effects come from the action of cholera toxin secreted by Vibrio cholerae in the intestinal lumen.
  • Despite the profound physiologic effects, there is no fever, inflammation, or direct injury to the bowel mucosa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

V. cholerae Growth and Structure

A
  • V. cholerae has a low tolerance for acid, but grows under alkaline (pH 8.0 to 9.5) conditions
  • Distinguished from other vibrios by its biochemical reactions, lipopolysaccharide (LPS), O antigenic structure, and production of cholera toxin (CT).
  • Over 200 O antigen serotypes, only two of which (O1 and O139) cause the disease cholera.
  • All strains capable of causing cholera also produce a colonization factor known as the toxin-coregulated pilus (TCP) because its expression is regulated together with CT.
  • In aquatic environments cells may enter a dormant state and polysaccharide biofilms are produced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

V. cholerae Cholera Toxin

A
  • CT is an AB type ADP-ribosylating toxin. Its molecule is an aggregate of multiple polypeptide chains organized into two catalytic subunits (A1, A2) and five binding (B) units. The B subunits bind to a GM1-ganglioside receptor found on the surface of many types of cells. Once bound, the A1 subunit enters the cell where it exerts its effect on the membraneassociated adenylate cyclase system.
  • Target of the toxic A1 subunit is a guanine nucleotide (G) protein (Gsa) that regulates activation of the adenylate cyclase system.
  • CT catalyzes the ADP-ribosylation of the G protein, rendering it unable to dissociate from the active adenylate cyclase complex.
  • Causes persistent activation of intracellular adenylate cyclase which stimulates the conversion of ATP to cyclic adenosine 3’, 5’-monophosphate (cAMP).
  • Accumulation of cAMP at the cell membrane causes hypersecretion of chloride, potassium, bicarbonate, and associated water molecules out of the cell into the intestinal lumen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cholera Epidemiology

A
  • Epidemic cholera is spread primarily by contaminated water under conditions of poor sanitation.
  • Endemic in the Indian subcontinent and Africa
  • Convalescent human carriage is brief
  • Short incubation period (two days) ensures that organisms ingested by others quickly enter the epidemic cycle (water supply).
  • Modern travel makes imported cases possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cholera Pathogenesis

A

V. cholerae’s colonization of the entire intestinal tract from the jejunum to the colon requires the organism to adhere to the epithelial surface by the TCP. The outstanding feature of V. cholerae pathogenicity is the ability of virulent strains to secrete CT which is responsible for the disease cholera. The water and electrolyte shift from the cell to the intestinal lumen is the fundamental cause of the watery diarrhea of cholera.

  • Outpouring of fluid and electrolytes is greatest in the small intestine,
  • Diarrheal fluid has approximately the same sodium content as plasma but also significant potassium and bicarbonate.
  • Result is dehydration (isotonic fluid loss), hypokalemia (potassium loss), and metabolic acidosis (bicarbonate loss).
  • Intestinal mucosa remains unaltered except for some hyperemia
  • Expression of virulence factors is coordinated in a 2-component system. The process begins when a transmembrane regulatory protein (ToxR) “senses” environmental changes in pH, osmolarity, and temperature. ToxR then activates other regulatory proteins which direct the synthesis of TCP and CT whose genes are located in separate pathogenicity islands (PAIs).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cholera Manifestations

A
  • Typical cholera has a rapid onset, beginning with abdominal fullness and discomfort, gurgling, rushes of peristalsis, and loose stools.
  • The stools quickly become watery, voluminous, almost odorless. They contain mucus flecks giving a gross appearance called rice-water stools.
  • There is no pus or blood in the stools and the patient is afebrile.
  • Extensive fluid loss and electrolyte imbalance lead to extreme dehydration, hypotension, and death if untreated.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cholera Diagnosis

A
  • A bacteriologic diagnosis is accomplished by isolation of V. cholerae from the stool.
  • Requires use of special selective medium (thiosulfate-citrate-bile salt-sucrose [TCBS] agar).
  • Clinical laboratories must be alerted to the suspicion of cholera especially outside the endemic areas.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cholera Treatment

A

•The outcome of cholera is dependent on balancing the diarrheal fluid and ionic losses with adequate fluid and electrolyte replacement.

-This is accomplished by oral and/or intravenous administration of solutions of glucose with near physiologic concentrations of sodium and chloride and higher than physiologic concentrations of potassium and bicarbonate.

•Antimicrobial therapy is secondary to fluid replacement.

-A single dose of azithromycin is optimal, but doxycycline, trimethoprim-sulfamethoxazole and fluoroquinolones are also effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cholera Prevention

A
  • Epidemic cholera, a disease of poor sanitation, does not persist where treatment and disposal of human waste is adequate.
  • As good sanitary conditions do not exist in much of the world, secondary local measures such as boiling or chlorination of water during epidemics are required.
  • The cases associated with crustaceans can be prevented by adequate cooking (10 minutes) and avoidance of recontamination from containers and food preparation surfaces.
  • Vaccines have been disappointing.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

V. vulnificus 3 Major Infections

A
  1. Acute gastroenteritis
  2. Necrotizing wound infections
  3. Invasive spesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

V. vulnificus Acute Gastroenteritis

A
  • Usually develops within 16 hours of eating contaminated (sea)food.
  • Manifests as vomiting, diarrhea, and abdominal pain.
  • Many patients develop distinctive bullous skin lesions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

V. vulnificus Necrotizing Wound Infections

A
  • Occur in broken or injured skin which is exposed to contaminated marine water (especially brackish water).
  • Pathogen enters via the broken skin, and patients may develop a blistering dermatitis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

V. vulnificus Invasive Sepsis

A
  • The bacterium enters the systemic circulation directly from the GI tract or broken skin to produce bacteremia and septicemia.
  • Invasion is characterized by the occurrence of blister-like skin lesions or bullae, and rapidly-spreading necrosis resembling necrotizing fasciitis.
  • Invasive sepsis can occur after eating raw or undercooked shellfish, especially oysters.
  • V. vulnificus is 80 times more likely to spread into the bloodstream in people with compromised immune systems, especially those with chronic liver disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

V. vulnificus Diagnosis

A
  • Culture of organism from wound or hemorrhagic bullae is recommended
  • All V. vulnificus isolates should be forwarded to a public health laboratory
  • Blood cultures are recommended if the patient is febrile, has hemorrhagic bullae, or has signs of sepsis
  • Marked left shift in WBC is common
  • Renal injury with rising serum creatinine level is also common
  • In severe infection, creatine kinase level is often elevated when necrotizing fasciitis or myonecrosis is present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

V. vulnificus Treatment

A
  • Debridement of necrotic tissue is of paramount importance; severe cases may require fasciotomy or limb amputation.
  • Antibiotic therapy
  • Doxycycline (100mg PO/IV twice a day for 7–14 days) and a third-generation cephalosporin (e.g., ceftazidime 1–2g IV/IM every 8 hours) is generally recommended.
  • A single-agent regimen with a fluoroquinolone such as levofloxacin, ciprofloxacin, or gatifloxacin has been reported to be at least as effective in an animal model as a regimen with doxycycline and a cephalosporin.
  • Doxycycline and fluoroquinolones are sometimes contraindicated in children.
  • Treat children with trimethoprim-sulfamethoxazole plus an aminoglycoside.
17
Q

V. vulnificus Prevention

A
  • Avoiding consumption of raw seafood especially in summer months
  • Avoiding swimming or brackish water contact when body has open wounds or cuts – especially where seawater temperatures are warm
18
Q

Camplylobacter genus

A
  • Gram -
  • spiral
  • oxidase +
  • microaerophilic
  • C. jejuni
19
Q

C. jejuni

A
  • Campylobacter jejuni infection typically begins with lower abdominal pain, which evolves into diarrhea over a matter of hours.
  • The diarrhea may be watery or dysenteric, with blood and pus in the stool.
  • Most patients are febrile.
  • The illness resolves spontaneously after a few days to a week.
20
Q

C. jejuni Organism

A
  • Curved, oxidase-positive, Gram-negative rods similar in morphology to vibrios.
  • Microaerophilic, that is, does not grow in air but requires oxygen at reduced tension (5- 10%) due to vulnerability of some of its enzyme systems to superoxides.
  • Growth usually requires 2 to 4 days
  • Cytolethal distending toxin (CDT) is a cytotoxin with an A/B structure.
21
Q

Campylobacter Enteritis Epidemiology

A
  • Primary reservoir is in animals, including sheep, cattle, chickens, wild birds, and many others.
  • Domestic animals such as dogs may also carry the organisms
  • Most common source of human infection is undercooked poultry
  • Worldwide distribution causing up to 30% of all infectious diarrheas
  • Outbreaks have been caused by contaminated water supplies and unpasteurized milk.
22
Q

Campylobacter Enteritis Pathogenesis

A
  • The infecting dose is low (few hundred cells, less than 1000), as volunteers have been infected with only a few hundred cells.
  • Once inside, they move in association with the cell’s microtubule structure rather than the actin microfilaments associated with many other invasive bacteria.
  • Injury is due to CDT and the action of lipooligosaccharides released in membrane vesicles.
23
Q

C. jejuni and GBS

A
  • There is an association between C. jejuni infection and the Guillain-Barre syndrome (GBS), an acute demyelinating neuropathy which is frequently preceded by an infection.
  • The molecular mimicry mechanism (type II hypersensitivity) involves antibody elicited by ganglioside-like epitopes in the C. jejuni LPS core oligosaccharide which cross-react with similar molecules in the host peripheral nerve myelin.
24
Q

Campylobacter Enteritis Manifestations

A
  • Typically begins 1-7 days after ingestion with fever and lower abdominal pain
  • Diarrheal stools usually contain blood and pus.
  • Self-limiting after 3 to 5 days
25
Q

Campylobacter Enteritis Diagnosis

A
  • Diagnosis is by isolation from the stool using a medium made selective for Campylobacter by inclusion of antimicrobial agents and microaerophilic incubation.
  • Campylobacter methods are part of the routine stool culture.
26
Q

Campylobacter Enteritis Treatment

A
  • Erythromycin or azithromycin are the treatments of choice but must be given early for maximal effect.
  • Fluoroquinolones are also effective, but resistance is becoming common.
27
Q

Helicobacter genus

A
  • Gram -
  • spiral
  • microaerophilic
  • makes urease
  • Helicobacter infections are limited to the mucosa of the stomach and most are asymptomatic even after many years.
  • Burning pain in the upper abdomen, accompanied by nausea and sometimes vomiting are symptoms of gastritis.
  • Ulcers may cause additional symptoms, depending on their anatomic location.
  • It is common for gastric and duodenal ulcers to be unrecognized by the patient until they cause frank bleeding or rupture.
  • H. pylori
28
Q

H. pylori

A
  • H. pylori has morphological and growth similarities to the campylobacters
  • Urease allows the organism to persist in low pH environments by the generation of ammonia
  • Vacuolating cytotoxin (VacA) causes apoptosis in eukaryotic cells it enters, causing multiple large cytoplasmic vacuoles generated by formation of channels in lysosomal and endosomal membranes.
  • Cag protein (CagA) induces changes in multiple cellular proteins and has a strong association with virulence.
  • Most H. pylori strains also contain a 30+ gene pathogenicity island (PAI). PAI genes code for elements of a secretion system which injects VacA, Cag and other proteins, into epithelial cells.
29
Q

Helicobacter Gastritis Epidemiology

A
  • Perhaps the most prevalent disease in the world
  • Mode of transmission is presumed to be fecal-oral
  • H. pylori is exclusive to humans. Other species cause gastritis in animals.
  • Once established the same strain persists for decades, probably for life.
  • The most common cause of gastritis, gastric ulcer, and duodenal ulcer.
  • Gastritis caused by Cag+ strains is acknowledged to be an antecedent cause of adenocarcinoma,
  • H. pylori has the dubious distinction of being the first bacterium declared a class I carcinogen by the World Health Organization.
30
Q

Helicobacter Gastritis Pathogenesis

A

In order to persist in the hostile environs of the stomach H. pylori employs multiple mechanisms to adhere to the gastric mucosa and survive the acid milieu of the stomach.

  • Motility provided by the flagella allows the organisms to swim to the less acid pH locale beneath the gastric mucus
  • Urease creates a more neutral pH microenvironment by ammonia production.
  • At the mucosa adherence is mediated by surface proteins
  • VACa: gastric mucosal injury
  • CagA: disrupts host cell cytoskeleton, signaling and polarity (precursor to gastric cancer)
31
Q

Helicobacter Gastritis Clinical

A
  • Either silent; or nausea/abdominal pain lasting up to 2 weeks
  • Acquisition likely via fecal-oral route
  • Gastritis and peptic ulcer disease upon progression (but may take years)
  • 10% - 20% pts get gastric or duodenal ulcers
  • 1-2% gastric cancer risk
32
Q

Helicobacter Gastritis Diagnosis

A
  • Diagnosis by endoscopy and culture
  • Urease very potent, so urease test is common as well
  • Elevated IgG and IgA
33
Q

Helicobacter Gastritis Treatment

A
  • Treatment via antibiotics
  • Bismuth salts, PPIs + Abx = cure rates >90%